The CLEARPATH DS-120™ is cleared by FDA as a tool for the measurement of autofluorescence by scanning the crystalline lens of the eye with a blue light. In independent scientific studies published in peer-reviewed journals, elevated autofluorescence measurements have been linked to high levels of advanced glycosylated end products which accumulate in the presence of diabetes. Breakthrough in Non-Invasive Lens Autofluorescence Detection Fluorescence vs. Age Prediction Ratio Chart Fluorescence Ratio Age Observed fluorescence ratios from healthy eyes of 127 healthy subjects, with no cataracts, from Freedom Meditech clinical study. NEW PRODUCT LAUNCH! @FreedomMeditech Follow Us MKT-005REVA
The Freedom-Meditech Clearpath ds 120
Jun 24, 2015
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
The CLEARPATH DS-120™ is cleared by FDA as a tool for the measurement of autofluorescence by scanning the crystalline lens of the eye with a blue light.
In independent scientific studies published in peer-reviewed journals, elevated autofluorescence measurements have been linked to high levels of advanced glycosylated end products which accumulate in the presence of diabetes.
Breakthrough in Non-Invasive Lens Autofluorescence Detection
Fluorescence vs. Age Prediction Ratio Chart
Fluo
resc
ence
Rat
io
Age
Observed fluorescence ratios from healthy eyes of 127 healthy subjects, with no cataracts, from Freedom Meditech clinical study.
NEW PRODUCT LAUNCH!
@FreedomMeditech
Follow Us
MKT-005REVA
NEW PRODUCT LAUNCH!
@FreedomMeditech
Follow Us
MKT-005REVA
Related Documents
